Les Meilleures Cliniques et Coûts des traitements de la maladie de Crohn en République de Corée 2026

Asan Medical Center is a top choice for Crohn’s disease. It hosts the first and largest specialized Inflammatory Bowel Disease center in Korea. This facility manages approximately 6,000 patients with Crohn's and ulcerative colitis. Other high-ranking Seoul-based hospitals like Severance Hospital and Seoul National University Hospital provide advanced multidisciplinary care.

• Asan Medical Center: Ranked 5th globally for gastroenterology by Newsweek in 2024.
• Advanced procedures: Centers offer hormone therapy, stem cell therapy, and laparoscopic resection.
• Digital healthcare: Seoul National University Hospital features complete digitalization to reduce errors.
• Expert specialists: Dr. Cheon Won Seok specializes in Crohn's disease at Na-Eun Hospital.

Bookimed Expert Insight: While major university hospitals prioritize complex surgery, Korea's focus on digital systems offers a significant advantage for Crohn's management. Seoul National University Bundang Hospital uses the BESTcare system to prevent medical errors. This high-tech approach ensures precise tracking of long-term medication and lab results for chronic inflammatory conditions.

Patient Consensus: Patients note that major university hospitals are dependable for treating acute flares. However, travelers should bring a local referral and plan for a translator to navigate the complex administrative steps at these large centers.

South Korea routinely uses advanced diagnostic technologies and innovative therapies to manage Crohn's disease. Standard clinical protocols include high-definition capsule endoscopy, biologics, and hormone therapy. Leading medical centers in Seoul also offer emerging treatments like arterial stem cell therapy for complex inflammatory cases.

• Diagnostic imaging: Specialized centers utilize capsule endoscopy to visualize small-bowel involvement.
• Advanced endoscopy: Specialists perform endoscopic submucosal dissection (ESD) for precise tissue management.
• Interventional procedures: Clinical teams routinely conduct colonoscopies with biopsies for staging inflammation.
• Stem cell therapy: Hospitals like RE:YOUTH specialize in arterial stem cell delivery methods.

Bookimed Expert Insight: While many patients seek Korea for aesthetics, the country’s gastroenterology infrastructure is built on massive scale. Large facilities like Seoul National University Bundang Hospital serve over 1,500,000 patients annually and operate fully digitalized environments. This high volume allows doctors like Dr. Cheon Won Seok to maintain subspecialized expertise in inflammatory bowel disease, which is often managed within oncology-grade diagnostic centers rather than small private clinics.

Surgery for Crohn’s disease is becoming more common in Korea as incidence rates rise. Statistics show 60% to 80% of Korean patients require surgery eventually. Early intervention rates are 9.1% within five years of diagnosis. Minimally invasive laparoscopic techniques now account for up to 50% of these procedures.

• Cumulative surgery risk: Up to 80% of patients need major surgery during their lifetime.
• Common procedures: Anal surgery for fistulas represents nearly 40% of all cases.
• Early intervention: Approximately 5% of patients undergo bowel resection within one year.
• Reoperation rates: About 31% of patients require a second surgery within 10 years.

Bookimed Expert Insight: Data from major Seoul centers shows a high concentration of complex cases. Asan Medical Center performs over 65,000 operations annually across all departments. Severance Hospital treats 1.6 million outpatients yearly and maintains JCI accreditation. Patients may prefer these high-volume facilities for their extensive experience with perianal complications.

Patient Consensus: Patients often worry about the high chance of recurrence after the first operation. Many note that choosing a specialist who uses laparoscopic methods makes recovery much easier.

South Korean centers manage Crohn-related fistulas using a multidisciplinary strategy focused on infection control and tissue healing. Specialized surgeons and gastroenterologists combine biologics with sphincter-sparing procedures like LIFT or stem cell therapy. These interventions aim to close tracts while fully preserving bowel continence.

• Infection control: Surgeons perform incision and drainage or seton placement to resolve perianal sepsis.
• Surgical choice: Doctors use fistulotomy for simple tracts and advancement flaps for complex cases.
• Sphincter preservation: Ligation of the intersphincteric fistula tract (LIFT) seals tracts without muscle damage.
• Biological therapy: Anti-TNF medications like infliximab prioritize permanent fistula closure and prevent recurrence.

Bookimed Expert Insight: South Korea is a pioneer in cellular medicine for Crohn's complications. Clinics like RE:YOUTH specialize in arterial delivery methods for stem cell therapy. This approach can be more effective than local injections. It delivers therapeutic cells through the blood supply directly to the inflamed perianal tissue.

Patient Consensus: Patients note that localized discussions on Korean treatment are rare in international circles. They emphasize the need to consult directly with Korean colorectal specialists who utilize advanced diagnostic tools like capsule endoscopy.